AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fightOn Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $1...
15 Aug, 2024, 12.47 PM IST
AstraZeneca sells cholesterol drug rights to Grünenthal for $320 millionAstraZeneca, which is among the front-runners in the race to develop a vaccine for the novel coronavirus, has been trying to focus on its c...
01 Dec, 2020, 01.27 PM IST
AstraZeneca Pharma India to close Bengaluru API unitDrug firm AstraZeneca Pharma India will close its Active Pharmaceutical Ingredient (API) unit at Bengaluru due to low demand for the produc...
03 Dec, 2015, 05.51 PM IST
Sun Pharma, AstraZeneca seal distribution dealThe drug majors have entered into a distribution services agreement to distribute AstraZeneca's heart disease treatment drug 'Axcer' in Ind...
02 Jun, 2015, 12.32 PM IST
AstraZeneca Pharma board approves delisting of company's shares from stock exchangesAstraZeneca Pharma today said its board has approved delisting of the company's shares from bourses, including BSE and the National Stock E...
18 Mar, 2014, 10.44 PM IST
AstraZeneca Pharma shares rise 3 per cent on board's approved delisitngShares of AstraZeneca Pharma rose by 3 per cent as its board has approved delisting of the company's shares from bourses like NSE, BSE etc.
18 Mar, 2014, 06.08 PM IST
AstraZeneca Pharma plunges 9% as board defers delisting offerAstraZeneca Pharma slipped as much as 8.8 per cent in intraday trade after the Indian arm of Swedish drug maker deferred delisting plans.
06 Mar, 2014, 04.55 PM IST
AstraZeneca jumps 20 per cent on delisting planAstraZeneca’s India unit has revived its plan of delisting the co from the stock markets, an announcement that sent company’s shares soarin...
04 Mar, 2014, 12.44 AM IST
AstraZeneca up 20% on delisting proposal, locked in upper circuit at Rs 1,110.90AstraZeneca said in the filing before markets opened on Monday that its board received a request from its promoter to initiate a voluntary ...
03 Mar, 2014, 11.22 AM IST
- AstraZeneca Pharma promoter to sell stake in Indian arm
AstraZeneca India today said its promoter AstraZeneca Pharmaceuticals AB Sweden plans to offload around 37 lakh shares through offer for sa...
24 May, 2013, 07.56 PM IST
AstraZeneca to receive over Rs 140 crore grant from promoterAstraZeneca Pharma AB would be provide the first tranche of Rs 74 cr to the Indian firm in the current financial year, it added.
06 May, 2013, 04.23 PM IST
- AstraZeneca Pharma hits 52-week low as promoter likely to reduce stake
AstraZeneca slipped over 11% to hit its 52-week low on reports that its promoter has decided to reduce shareholding.
06 Mar, 2013, 09.49 AM IST
- Cognizant inks multi-year agreement with AstraZeneca
Cognizant has inked a deal with AstraZeneca to deliver comprehensive biostatistics and medical reporting services for generating clinical s...
30 Nov, 2011, 05.06 PM IST
- AstraZeneca Pharma to delist from India; shares jump 20 pc
AstraZeneca Pharma India today said it will de-list itself from domestic stock exchanges, fueling a jump of 20 per cent in its stock price ...
29 Jun, 2010, 02.27 PM IST
- Genpact bags F&A services contract from AstraZeneca
The multi-million dollar contract will deliver services to over 50 countries, it added.
10 Dec, 2009, 08.42 PM IST
- AstraZeneca Pharma NCDs get P1 rating
CRISIL has assigned ‘P1+’ rating to the short term secured fully-paid redeemable non-convertible bonus debenture issue of AstraZeneca Pharm...
05 Oct, 2007, 10.52 AM IST
- AstraZeneca to get drugs made in India
AstraZeneca, Britain’s second largest pharmaceutical company, is planning to outsource all its drug manufacturing activities to India and o...
18 Sep, 2007, 02.50 AM IST